Thrivent Financial for Lutherans’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,946
| Closed | -$214K | – | 2467 |
|
2023
Q1 | $214K | Hold |
2,946
| – | – | ﹤0.01% | 2370 |
|
2022
Q4 | $241K | Hold |
2,946
| – | – | ﹤0.01% | 2304 |
|
2022
Q3 | $279K | Hold |
2,946
| – | – | ﹤0.01% | 2248 |
|
2022
Q2 | $573K | Buy |
+2,946
| New | +$573K | ﹤0.01% | 2026 |
|
2021
Q2 | – | Sell |
-1,785
| Closed | -$641K | – | 2456 |
|
2021
Q1 | $641K | Sell |
1,785
-1,850
| -51% | -$664K | ﹤0.01% | 2129 |
|
2020
Q4 | $1.78M | Buy |
3,635
+1,514
| +71% | +$743K | ﹤0.01% | 1389 |
|
2020
Q3 | $687K | Sell |
2,121
-17
| -0.8% | -$5.51K | ﹤0.01% | 1806 |
|
2020
Q2 | $779K | Hold |
2,138
| – | – | ﹤0.01% | 1666 |
|
2020
Q1 | $455K | Buy |
+2,138
| New | +$455K | ﹤0.01% | 1768 |
|